Bausch Health Companies Inc
Bausch Health Companies Inc/ CA0717341071 /
BHC
|
2024-04-26 4:01:01 PM
|
Chg.
+0.03
|
Volume |
Bid4:01:01 PM |
Ask4:01:01 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
8.65USD
|
+0.29%
|
55,040
Turnover: 407,393.30 |
8.64Bid Size: 900 |
8.65Ask Size: 600 |
3.15 bill.USD |
- |
- |
Business description
Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
Management board & Supervisory board
| CEO |
| Thomas J. Appio |
| Management board |
| Tom Vadaketh, Seana Carson, Mirza Dautbegovic, Kathleen Fitzpatrick, Jeff Hartness, Cees Heiman, Graham Jackson, Jiny Kim, Donald Pearl, Josh Coyle, Nicola Kayel, Dr. Tage Ramakrishna, M.D., Tom Stern, Fernando Zarate |
| Supervisory board |
| John A. Paulson, Thomas J. Appio, Brett M. Icahn, Sarah B. Kavanagh, Steven D. Miller, Dr. Richard Mulligan, Robert N. Power, Russel C. Robertson, Thomas W. Ross, Sr., Amy B. Wechsler, M.D. |
Company data
| Name: |
Bausch Health Companies Inc. |
| Address: |
2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada |
| Phone: |
+1(800) 361-1448 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.bauschhealth.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
Arthur Shannon |
| IR phone: |
+1-877-281-6642 |
| IR Fax: |
- |
| IR e-mail: |
ir@bauschhealth.com
|
Company calendar
|
CW 18 | 2024-05-02
Interim Report 1st Quarter/3 Months
|
